Status:
COMPLETED
Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
Lead Sponsor:
59th Medical Wing
Conditions:
Abscess
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Patients will be enrolled in a multi-center study to prospectively evaluate outcome after treatment for an uncomplicated skin abscess. All patients will receive incision and drainage and wound culture...
Eligibility Criteria
Inclusion
- all patients age 18-55 who present to the emergency department with a skin abscess that requires incision and drainage.
Exclusion
- patients with diabetes, HIV, cancer or other immunocompromised patients
- patients who received antibiotics within one week of presentation or were hospitalized in previous month will be excluded to minimize potential confounding variables
- pregnant and breastfeeding patients will also be excluded due to possible safety concerns with antibiotic treatment
- basic Military Trainees will also be excluded from participation
- patients with abscesses on head, face, perirectal, or periananal regions, abscesses with known tracks or fistulas to deeper structures, or abscesses requiring surgical drainage in an operating room are excluded
- patients with sulfa allergy will be excluded.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00829686
Start Date
June 1 2008
End Date
June 1 2008
Last Update
June 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilford Hall Medical Center
Lackland Air Force Base, Texas, United States